95 related articles for article (PubMed ID: 3172842)
1. Cytogenetic association and prognostic significance of bone marrow blast cell terminal transferase in patients with acute myeloblastic leukemia.
Schachner J; Kantarjian H; Dalton W; McCredie K; Keating M; Freireich EJ
Leukemia; 1988 Oct; 2(10):667-71. PubMed ID: 3172842
[TBL] [Abstract][Full Text] [Related]
2. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.
Lee EJ; Yang J; Leavitt RD; Testa JR; Civin CI; Forrest A; Schiffer CA
Leukemia; 1992 Nov; 6(11):1203-9. PubMed ID: 1279324
[TBL] [Abstract][Full Text] [Related]
3. Terminal deoxynucleotidyl transferase in acute leukemias by direct immunofluorescence.
Nair CN; Gothoskar BP; Gladstone B; Badrinath Y; Chhajlani V; Karnik M; Nerurkar A; Damle SR; Redkar SL; Gopal R
Neoplasma; 1987; 34(3):305-11. PubMed ID: 3302737
[TBL] [Abstract][Full Text] [Related]
4. Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia.
Drexler HG; Sperling C; Ludwig WD
Leukemia; 1993 Aug; 7(8):1142-50. PubMed ID: 7688837
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of initial terminal deoxynucleotidyl transferase determinations in childhood acute leukemias.
Kalwinsky DK; Weatherred WH; Dahl GV; Bowman WP; Melvin SL; Coleman MS; Bollum FJ
Cancer Res; 1981 Jul; 41(7):2877-81. PubMed ID: 7018672
[TBL] [Abstract][Full Text] [Related]
6. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
Shumak KH; Baker MA; Taub RN; Coleman MS
Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
[TBL] [Abstract][Full Text] [Related]
7. Terminal transferase surveillance of remission bone marrows in childhood acute lymphoblastic leukemia: improved sensitivity with countercurrent centrifugal elutriation.
Lauer SJ; Lyman S; Kirchner PA; Gottschall JL; Camitta BM; Casper JT
J Clin Lab Immunol; 1985 Jan; 16(1):17-22. PubMed ID: 3856682
[TBL] [Abstract][Full Text] [Related]
8. Terminal deoxynucleotidyl transferase-positive acute myeloblastic leukemia.
McGraw TP; Folds JD; Bollum FJ; Stass SA
Am J Hematol; 1981; 10(3):251-8. PubMed ID: 6264782
[TBL] [Abstract][Full Text] [Related]
9. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
[TBL] [Abstract][Full Text] [Related]
10. Use of terminal deoxynucleotidyl transferase in the diagnosis of leukemia.
Morse EE; Gaffney J; Donskoy E; Pisciotto P; Altman A; Quinn J; Goldschneider I
Ann Clin Lab Sci; 1983; 13(2):128-32. PubMed ID: 6344744
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of terminal transferase and adenosine deaminase in acute and chronic myeloid leukemia.
Bertazzoni U; Brusamolino E; Isernia P; Scovassi AI; Torsello S; Lazzarino M; Bernasconi C
Blood; 1982 Sep; 60(3):685-92. PubMed ID: 7049266
[TBL] [Abstract][Full Text] [Related]
12. Terminal deoxynucleotidyl transferase and CD7 expression in acute myeloid leukemias are not associated with a high frequency of immunoglobulin and/or T cell receptor gene rearrangement.
Willière G; Stockinger H; Köller U; Majdic O; Schnabl E; Lutz D; Bettelheim P; Knapp W
Leukemia; 1990 Apr; 4(4):278-81. PubMed ID: 1694941
[TBL] [Abstract][Full Text] [Related]
13. [Implications of terminal deoxynucleotidyl transferase activity in various forms of childhood leukemia (author's transl)].
Welte K; Ebener U; Hinderfeld L; Ritter J; Henze G; Kornhuber B
Klin Padiatr; 1981 May; 193(3):165-71. PubMed ID: 6943391
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia.
Del Poeta G; Venditti A; Stasi R; Aronica G; Cox MC; Buccisano F; Tamburini A; Bruno A; Maurillo L; Battaglia A; Suppo G; Epiceno AM; Del Moro B; Masi M; Amadori S; Papa G
Leuk Res; 1999 May; 23(5):451-65. PubMed ID: 10374859
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of terminal transferase and adenosine deaminase in leukemia.
Brusamolino E; Bertazzoni U; Isernia P; Ginelli E; Scovassi AI; Zurlo MG; Plevani P; Sacchi N; Bernasconi C
Adv Exp Med Biol; 1982; 145():279-303. PubMed ID: 7051780
[TBL] [Abstract][Full Text] [Related]
16. Terminal-deoxynucleotidyl-transferase immunofluorescence on bone marrow smears: serial studies on 28 patients.
Miller WM; Stass SA; Schumacher HR; Bollum FJ
Am J Hematol; 1981; 10(1):1-7. PubMed ID: 7020412
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of leukemia cell terminal transferase measurements.
McCaffrey R; Lillquist A; Sallan S; Cohen E; Osband M
Cancer Res; 1981 Nov; 41(11 Pt 2):4814-20. PubMed ID: 7028251
[TBL] [Abstract][Full Text] [Related]
18. Terminal deoxynucleotidyl transferase expression in acute myelogenous leukemia and myelodysplasia as determined by flow cytometry.
Huh YO; Smith TL; Collins P; Bueso-Ramos C; Albitar M; Kantarjian HM; Pierce SA; Freireich EJ
Leuk Lymphoma; 2000 Apr; 37(3-4):319-31. PubMed ID: 10752983
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic changes in a case of blast crisis of CML: characterization by TdT, cytochemistry, and cytogenetics.
Paietta E; Schwarzmeier JD
Scand J Haematol; 1981 Oct; 27(4):241-6. PubMed ID: 6955937
[TBL] [Abstract][Full Text] [Related]
20. Terminal deoxynucleotidyl transferase positive acute myeloid leukaemia: an association with immature myeloblastic leukaemia.
Parreira A; Pombo de Oliveira MS; Matutes E; Foroni L; Morilla R; Catovsky D
Br J Haematol; 1988 Jun; 69(2):219-24. PubMed ID: 3164631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
